Cargando…
Antimicrobial Activity of Zabofloxacin against Clinically Isolated Streptococcus pneumoniae
Zabofloxacin is a novel fluoroquinolone agent that has potent activity against gram-positive pathogens. In this study, we confirmed that zabofloxacin showed the most potent in vitro and in vivo activities against drug-resistant Streptococcus pneumoniae. Among the fluoroquinolone compounds, zabofloxa...
Autores principales: | Park, Hee-Soo, Oh, Sang-Hun, Kim, Hye-Shin, Choi, Dong-Rack, Kwak, Jin-Hwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273590/ https://www.ncbi.nlm.nih.gov/pubmed/27869677 http://dx.doi.org/10.3390/molecules21111562 |
Ejemplares similares
-
Delafloxacin, Finafloxacin, and Zabofloxacin: Novel Fluoroquinolones in the Antibiotic Pipeline
por: Kocsis, Béla, et al.
Publicado: (2021) -
In Vitro and In Vivo Activity of Zabofloxacin and Other Fluoroquinolones Against MRSA Isolates from A University Hospital in Egypt
por: MOHAMED, NELLY M., et al.
Publicado: (2019) -
Antibacterial Activity of LCB10-0200 against Klebsiella pneumoniae
por: Oh, Sang-Hun, et al.
Publicado: (2021) -
Serotype Distribution and Antimicrobial Resistance of Invasive and Noninvasive Streptococcus pneumoniae Isolates in Korea between 2014 and 2016
por: Park, Dong-Chul, et al.
Publicado: (2019) -
Chemical structure and pharmacokinetics of novel quinolone agents represented by avarofloxacin, delafloxacin, finafloxacin, zabofloxacin and nemonoxacin
por: Kocsis, Bela, et al.
Publicado: (2016)